Serotonergic psychedelic: Difference between revisions

Line 195:

* {{cite journal|last1=Nichols|first1=D. E.|title=Psychedelics|journal=Pharmacological Reviews|volume=68|issue=2|year=2016|pages=264–355|issn=1521-0081|doi=10.1124/pr.115.011478}}

* {{cite journal|last1=Geyer|first1=M.A.|last2=Nichols|first2=D.E.|last3=Vollenweider|first3=F.X.|title=Serotonin-Related Psychedelic Drugs|year=2009|pages=731–738|doi=10.1016/B978-008045046-9.01160-8}}

* Nichols, C. D., & Sanders-Bush, E. (2001). "Serotonin Receptor Signaling and Hallucinogenic Drug Action". ''Heffter Rev Psychedelic Res'', 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf

* Nichols, C. D., & Sanders-Bush, E. (2001). "Serotonin Receptor Signaling and Hallucinogenic Drug Action". Heffter Rev Psychedelic Res, 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf

* {{cite journal|last1=Halberstadt|first1=Adam L.|title=Recent advances in the neuropsychopharmacology of serotonergic hallucinogens|journal=Behavioural Brain Research|volume=277|year=2015|pages=99–120|issn=01664328|doi=10.1016/j.bbr.2014.07.016}}

* {{cite journal|last1=Beique|first1=J.-C.|last2=Imad|first2=M.|last3=Mladenovic|first3=L.|last4=Gingrich|first4=J. A.|last5=Andrade|first5=R.|title=Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex|journal=Proceedings of the National Academy of Sciences|volume=104|issue=23|year=2007|pages=9870–9875|issn=0027-8424|doi=10.1073/pnas.0700436104}}

Line 205:

===Specific Examples===

* Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). ~~'''''~~The Pharmacology of Lysergic Acid Diethylamide: A Review~~'''''~~, 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x

* Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The Pharmacology of Lysergic Acid Diethylamide: A Review, 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x

* Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). ~~'''''~~Neural correlates of the LSD experience revealed by multimodal neuroimaging.~~'''''~~ Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113

* Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113

* Tylš, F., Páleníček, T., & Horáček, J. (2014). ~~'''''~~Psilocybin–summary of knowledge and new perspectives.~~''''' ''~~European Neuropsychopharmacology'', 24(3), 342-356. http://doi.org/10.1016/j.euroneuro.2013.12.006.

* Tylš, F., Páleníček, T., & Horáček, J. (2014). Psilocybin–summary of knowledge and new perspectives. European Neuropsychopharmacology, 24(3), 342-356. http://doi.org/10.1016/j.euroneuro.2013.12.006.

* Nichols, C. D., Garcia, E. E., & Sanders-bush, E. (2003). '''''Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration''''', 111, 182–188. PMID: 12654518

==References==

[[Category:Psychedelic]][[Category:Psychoactive substance]]

@@ Line 195: / Line 195: @@
 * {{cite journal|last1=Nichols|first1=D. E.|title=Psychedelics|journal=Pharmacological Reviews|volume=68|issue=2|year=2016|pages=264–355|issn=1521-0081|doi=10.1124/pr.115.011478}}
 * {{cite journal|last1=Geyer|first1=M.A.|last2=Nichols|first2=D.E.|last3=Vollenweider|first3=F.X.|title=Serotonin-Related Psychedelic Drugs|year=2009|pages=731–738|doi=10.1016/B978-008045046-9.01160-8}}
-* Nichols, C. D., & Sanders-Bush, E. (2001). "Serotonin Receptor Signaling and Hallucinogenic Drug Action". ''Heffter Rev Psychedelic Res'', 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf
+* Nichols, C. D., & Sanders-Bush, E. (2001). "Serotonin Receptor Signaling and Hallucinogenic Drug Action". Heffter Rev Psychedelic Res, 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf
 * {{cite journal|last1=Halberstadt|first1=Adam L.|title=Recent advances in the neuropsychopharmacology of serotonergic hallucinogens|journal=Behavioural Brain Research|volume=277|year=2015|pages=99–120|issn=01664328|doi=10.1016/j.bbr.2014.07.016}}
 * {{cite journal|last1=Beique|first1=J.-C.|last2=Imad|first2=M.|last3=Mladenovic|first3=L.|last4=Gingrich|first4=J. A.|last5=Andrade|first5=R.|title=Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex|journal=Proceedings of the National Academy of Sciences|volume=104|issue=23|year=2007|pages=9870–9875|issn=0027-8424|doi=10.1073/pnas.0700436104}}
@@ Line 205: / Line 205: @@
 ===Specific Examples===
-* Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). '''''The Pharmacology of Lysergic Acid Diethylamide: A Review''''', 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x
+* Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The Pharmacology of Lysergic Acid Diethylamide: A Review, 14, 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x
-* Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). '''''Neural correlates of the LSD experience revealed by multimodal neuroimaging.''''' Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113
+* Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113
-* Tylš, F., Páleníček, T., & Horáček, J. (2014). '''''Psilocybin–summary of knowledge and new perspectives.''''' ''European Neuropsychopharmacology'', 24(3), 342-356. http://doi.org/10.1016/j.euroneuro.2013.12.006.
+* Tylš, F., Páleníček, T., & Horáček, J. (2014). Psilocybin–summary of knowledge and new perspectives. European Neuropsychopharmacology, 24(3), 342-356. http://doi.org/10.1016/j.euroneuro.2013.12.006.
-* Nichols, C. D., Garcia, E. E., & Sanders-bush, E. (2003). '''''Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration''''', 111, 182–188. PMID: 12654518
 ==References==
 <references/>
 [[Category:Psychedelic]][[Category:Psychoactive substance]]